The  ||| S:0 E:4 ||| DT
osteoprotegerin ||| S:4 E:19 ||| JJ
/ ||| S:19 E:20 ||| NNP
RANK ||| S:20 E:24 ||| NNP
/ ||| S:24 E:25 ||| NNP
RANKL  ||| S:25 E:31 ||| NNP
system ||| S:31 E:37 ||| NN
:  ||| S:37 E:39 ||| :
a  ||| S:39 E:41 ||| DT
bone  ||| S:41 E:46 ||| NN
key  ||| S:46 E:50 ||| NN
to  ||| S:50 E:53 ||| TO
vascular  ||| S:53 E:62 ||| VB
disease  ||| S:62 E:70 ||| NN
Osteoporosis  ||| S:70 E:83 ||| NNP
and  ||| S:83 E:87 ||| CC
atherosclerosis  ||| S:87 E:103 ||| NNS
are  ||| S:103 E:107 ||| VBP
degenerative  ||| S:107 E:120 ||| JJ
disorders  ||| S:120 E:130 ||| NNS
of  ||| S:130 E:133 ||| IN
old  ||| S:133 E:137 ||| JJ
age  ||| S:137 E:141 ||| NN
that  ||| S:141 E:146 ||| WDT
often  ||| S:146 E:152 ||| RB
present  ||| S:152 E:160 ||| VB
together ||| S:160 E:168 ||| RB
,  ||| S:168 E:170 ||| ,
but  ||| S:170 E:174 ||| CC
recently  ||| S:174 E:183 ||| RB
it  ||| S:183 E:186 ||| PRP
has  ||| S:186 E:190 ||| VBZ
been  ||| S:190 E:195 ||| VBN
suggested  ||| S:195 E:205 ||| VBN
that  ||| S:205 E:210 ||| IN
the  ||| S:210 E:214 ||| DT
association  ||| S:214 E:226 ||| NN
between  ||| S:226 E:234 ||| IN
osteoporosis  ||| S:234 E:247 ||| NN
and  ||| S:247 E:251 ||| CC
cardio-vascular  ||| S:251 E:267 ||| JJ
diseases  ||| S:267 E:276 ||| NNS
is  ||| S:276 E:279 ||| VBZ
not  ||| S:279 E:283 ||| RB
just  ||| S:283 E:288 ||| RB
due  ||| S:288 E:292 ||| JJ
to  ||| S:292 E:295 ||| TO
the  ||| S:295 E:299 ||| DT
aging  ||| S:299 E:305 ||| JJ
process ||| S:305 E:312 ||| NN
.  ||| S:312 E:314 ||| .
The  ||| S:314 E:318 ||| DT
osteoprotegerin  ||| S:318 E:334 ||| NN
( ||| S:334 E:335 ||| -LRB-
OPG ||| S:335 E:338 ||| NNP
) ||| S:338 E:339 ||| -RRB-
/ ||| S:339 E:340 ||| CD
receptor  ||| S:340 E:349 ||| NN
activator  ||| S:349 E:359 ||| NN
of  ||| S:359 E:362 ||| IN
nuclear  ||| S:362 E:370 ||| JJ
factor-kB  ||| S:370 E:380 ||| NN
( ||| S:380 E:381 ||| -LRB-
RANK ||| S:381 E:385 ||| NNP
) ||| S:385 E:386 ||| -RRB-
/ ||| S:386 E:387 ||| FW
RANK  ||| S:387 E:392 ||| FW
ligand  ||| S:392 E:399 ||| FW
( ||| S:399 E:400 ||| -LRB-
RANKL ||| S:400 E:405 ||| NNP
)  ||| S:405 E:407 ||| -RRB-
system  ||| S:407 E:414 ||| NN
has  ||| S:414 E:418 ||| VBZ
been  ||| S:418 E:423 ||| VBN
identified  ||| S:423 E:434 ||| VBN
as  ||| S:434 E:437 ||| IN
a  ||| S:437 E:439 ||| DT
possible  ||| S:439 E:448 ||| JJ
mediator  ||| S:448 E:457 ||| NN
of  ||| S:457 E:460 ||| IN
arterial  ||| S:460 E:469 ||| JJ
calcification  ||| S:469 E:483 ||| NNS
suggesting  ||| S:483 E:494 ||| VBG
common  ||| S:494 E:501 ||| JJ
links  ||| S:501 E:507 ||| NNS
between  ||| S:507 E:515 ||| IN
osteoporosis  ||| S:515 E:528 ||| NN
and  ||| S:528 E:532 ||| CC
vascular  ||| S:532 E:541 ||| JJ
diseases ||| S:541 E:549 ||| NNS
.  ||| S:549 E:551 ||| .
Since  ||| S:551 E:557 ||| IN
the  ||| S:557 E:561 ||| DT
discovery  ||| S:561 E:571 ||| NN
of  ||| S:571 E:574 ||| IN
the  ||| S:574 E:578 ||| DT
OPG ||| S:578 E:581 ||| NNP
/ ||| S:581 E:582 ||| NNP
RANK ||| S:582 E:586 ||| NNP
/ ||| S:586 E:587 ||| NNP
RANKL  ||| S:587 E:593 ||| NNP
system ||| S:593 E:599 ||| NN
,  ||| S:599 E:601 ||| ,
much  ||| S:601 E:606 ||| RB
has  ||| S:606 E:610 ||| VBZ
been  ||| S:610 E:615 ||| VBN
learned  ||| S:615 E:623 ||| VBN
about  ||| S:623 E:629 ||| IN
its  ||| S:629 E:633 ||| PRP$
role  ||| S:633 E:638 ||| NN
in  ||| S:638 E:641 ||| IN
controlling  ||| S:641 E:653 ||| VBG
skeletal  ||| S:653 E:662 ||| JJ
biology ||| S:662 E:669 ||| NN
;  ||| S:669 E:671 ||| :
however ||| S:671 E:678 ||| RB
,  ||| S:678 E:680 ||| ,
its  ||| S:680 E:684 ||| PRP$
role  ||| S:684 E:689 ||| NN
in  ||| S:689 E:692 ||| IN
the  ||| S:692 E:696 ||| DT
context  ||| S:696 E:704 ||| NN
of  ||| S:704 E:707 ||| IN
vascular  ||| S:707 E:716 ||| JJ
biology  ||| S:716 E:724 ||| NN
is  ||| S:724 E:727 ||| VBZ
only  ||| S:727 E:732 ||| RB
beginning  ||| S:732 E:742 ||| VBG
to  ||| S:742 E:745 ||| TO
be  ||| S:745 E:748 ||| VB
explored ||| S:748 E:756 ||| NNS
.  ||| S:756 E:758 ||| .
It  ||| S:758 E:761 ||| PRP
has  ||| S:761 E:765 ||| VBZ
been  ||| S:765 E:770 ||| VBN
suggested  ||| S:770 E:780 ||| VBN
that  ||| S:780 E:785 ||| IN
OPG  ||| S:785 E:789 ||| NNP
might  ||| S:789 E:795 ||| MD
act  ||| S:795 E:799 ||| VB
as  ||| S:799 E:802 ||| IN
an  ||| S:802 E:805 ||| DT
autocrine ||| S:805 E:814 ||| JJ
/ ||| S:814 E:815 ||| CD
paracrine  ||| S:815 E:825 ||| JJ
regulator  ||| S:825 E:835 ||| NN
of  ||| S:835 E:838 ||| IN
vascular  ||| S:838 E:847 ||| JJ
calcification  ||| S:847 E:861 ||| NN
and  ||| S:861 E:865 ||| CC
might  ||| S:865 E:871 ||| MD
be  ||| S:871 E:874 ||| VB
useful  ||| S:874 E:881 ||| JJ
as  ||| S:881 E:884 ||| IN
a  ||| S:884 E:886 ||| DT
serum  ||| S:886 E:892 ||| JJ
marker  ||| S:892 E:899 ||| NN
of  ||| S:899 E:902 ||| IN
vascular  ||| S:902 E:911 ||| JJ
disease ||| S:911 E:918 ||| NN
.  ||| S:918 E:920 ||| .
However ||| S:920 E:927 ||| RB
,  ||| S:927 E:929 ||| ,
the  ||| S:929 E:933 ||| DT
exact  ||| S:933 E:939 ||| JJ
role  ||| S:939 E:944 ||| NN
of  ||| S:944 E:947 ||| IN
OPG  ||| S:947 E:951 ||| NNP
( ||| S:951 E:952 ||| -LRB-
or  ||| S:952 E:955 ||| CC
RANKL ||| S:955 E:960 ||| NNP
/ ||| S:960 E:961 ||| NNP
RANK ||| S:961 E:965 ||| NNP
)  ||| S:965 E:967 ||| -RRB-
in  ||| S:967 E:970 ||| IN
vascular  ||| S:970 E:979 ||| JJ
calcification  ||| S:979 E:993 ||| NN
is  ||| S:993 E:996 ||| VBZ
still  ||| S:996 E:1002 ||| RB
not  ||| S:1002 E:1006 ||| RB
completely  ||| S:1006 E:1017 ||| RB
understood ||| S:1017 E:1027 ||| VBN
.  ||| S:1027 E:1029 ||| .
This  ||| S:1029 E:1034 ||| DT
review  ||| S:1034 E:1041 ||| NN
aims  ||| S:1041 E:1046 ||| VBZ
to  ||| S:1046 E:1049 ||| TO
report  ||| S:1049 E:1056 ||| VB
the  ||| S:1056 E:1060 ||| DT
recent  ||| S:1060 E:1067 ||| JJ
findings  ||| S:1067 E:1076 ||| NNS
on  ||| S:1076 E:1079 ||| IN
the  ||| S:1079 E:1083 ||| DT
relationship  ||| S:1083 E:1096 ||| NN
between  ||| S:1096 E:1104 ||| IN
osteoporosis  ||| S:1104 E:1117 ||| NN
and  ||| S:1117 E:1121 ||| CC
OPG ||| S:1121 E:1124 ||| NNP
/ ||| S:1124 E:1125 ||| NNP
RANK ||| S:1125 E:1129 ||| NNP
/ ||| S:1129 E:1130 ||| NNP
RANKL-mediated  ||| S:1130 E:1145 ||| JJ
vascular  ||| S:1145 E:1154 ||| JJ
disease ||| S:1154 E:1161 ||| NN
.  ||| S:1161 E:1163 ||| .
